A comprehensive view of Combination Therapy. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
AstraZeneca picks Biologics by McKesson as a specialty pharmacy provider for TRUQAP, an FDA-approved oral treatment for certain types of advanced or metastatic breast cancer
Published:
December 04, 2023
by ENP Newswire
|
Australia Patent: F. HOFFMANN-LA ROCHE, CHUGAI SEIYAKU File Application for 'COMBINATION THERAPY FOR CANCER TREATMENT'
Published:
December 01, 2023
by Australian Government
|
Eli Lilly and Company Submits Chinese Patent Application for Combination Therapy of Lasmidentant and CGRP Antagonists for the Treatment of Migraine
Published:
November 25, 2023
by Pharmaceutical Patent News
|
AstraZeneca Seeks Patent for Combination Therapy for Treating Cancer
Published:
November 25, 2023
by Pharmaceutical Patent News
|
Novartis AG and Univ Texas Apply for Patent on Combination Therapy
Published:
November 25, 2023
by Pharmaceutical Patent News
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count